Cart
sales@molnova.com
CCF0058981
CAS No. 2708934-53-4
CCF0058981 ( —— )
Catalog No. M28541 CAS No. 2708934-53-4
CCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 178 | Get Quote |
|
| 10MG | 295 | Get Quote |
|
| 25MG | 621 | Get Quote |
|
| 50MG | 1008 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 500MG | 2655 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCF0058981
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.
-
DescriptionCCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNF-κB;NOS;ROS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2708934-53-4
-
Formula Weight442.9
-
Molecular FormulaC24H19ClN6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N(C=1C=CC(=CC1)C2=CN=CN2)CC=3C=CC=C(Cl)C3)CN4N=NC=5C=CC=CC54
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.C Li, et al.Compounds from the bark of Illicium tsaii and their anti-inflammatory activity. Planta Medica. 2014 July; 80.
molnova catalog
related products
-
Raffinose
After treatment with CVGI, Raffinose family oligosaccharide was hydrolyzed effectively to yield galactose and sucrose.
-
Morusin
Morusin possesses antitumor effects of cell lines including HT-29, A549, MCF-7 and MDA-MB-231, through suppressing STAT3 and NFκB attenuation mediated apoptosis induction.
-
Sodium picosulfate m...
Sodium picosulfate monohydrate inhibits absorption of water and electrolytes, and increases their secretion.
